Neoadjuvant chemotherapy for locally advanced cervix cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Neoadjuvant Chemotherapy for Locally Advanced Cervix Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437172/all/Neoadjuvant_chemotherapy_for_locally_advanced_cervix_cancer.
Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437172/all/Neoadjuvant_chemotherapy_for_locally_advanced_cervix_cancer. Accessed November 6, 2025.
Neoadjuvant chemotherapy for locally advanced cervix cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437172/all/Neoadjuvant_chemotherapy_for_locally_advanced_cervix_cancer
Neoadjuvant Chemotherapy for Locally Advanced Cervix Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 November 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437172/all/Neoadjuvant_chemotherapy_for_locally_advanced_cervix_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neoadjuvant chemotherapy for locally advanced cervix cancer
ID - 437172
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437172/all/Neoadjuvant_chemotherapy_for_locally_advanced_cervix_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

